Insulin icodec-abae (Awiqli) coverage criteria
Customize your policy alerts
Sign up for QualChoice Policy HIM.PA.180 alerts
Get alerted when Policy HIM.PA.180 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, prior authorization, and coverage criteria for Awiqli (insulin icodec-abae) for adults with type 2 diabetes mellitus under QualChoice HIM/ICHRA lines of business; applies to providers requesting coverage and prior authorization.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.